medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2011, Number 05

<< Back Next >>

Ginecol Obstet Mex 2011; 79 (05)

Placental villous lesions in HIV-1 infection treated with zidovudine

Castejón SOC, López GAJ, Pérez YLM , Castejón MOC

Language: Spanish
References: 42
Page: 269-279
PDF size: 519.65 Kb.


ABSTRACT

Background: HIV-1 reaches the placenta through the maternal-fetal transmission from an infected uterus. This virus has cytolytic capabilities. The placenta in its maturation process has regressive or degenerative changes within certain limits, are considered normal. However, factors such as virus and antiretrovirals, can increase the proportion of these lesions.
Objective: To evaluate morphological changes in placental villi of pregnant women infected with HIV-1 treated with AZT.
Material and Methods: descriptive, prospective, comparative, with non-probability sampling of observations in villi as units of analysis of the placentas from the group of patients with HIV-1 infection and zidovudine regimen and of the control group of four placentas from HIV negative patients. Both groups in the last trimester of pregnancy. H-E staining was used in 25 films from five placental regions of the study group and four from the control group, using a protocol of 6 variables identifying syncytial knots, fibrinoid changes, villous edema, stromal fibrosis, calcification and villous immaturity. Observations were analyzed using ANOVA as a 2 x 5 factorial arrangement with 4 replications subsampling and split plot design and Tukey test.
Results: Chorionic villi showed percentages of alterations that exceed the normal range. It showed significant differences (p‹0.05) between the placentas exposed to HIV-1 and AZT and normal placentas in relation to the percentage of villi affected by 5 variables, except fibrosis.
Conclusions: The lesions may be increasing the vertical transmission of HIV-1. We also found evidence that the placenta is not in the best conditions for the transfer of gases, nutrients and metabolites, which could promote a decrease in birth weight and placental weight.


REFERENCES

  1. D'Costa GF, Khadke K, Patil YV. Pathology of placenta in HIV infection. Indian J Pathol Microbiol, 2007; 50:515-519.

  2. Miller RK, Ebbesen P, Popek EJ, Palliotti B, Sleikh A, Roberts D et al. The role of the placenta in the vertical transmission of HIV and other infections agents - A workshop report. Trophoblast Research, 1998; 12:225-235.

  3. Jauniaux E, Nessmann C, Imbert MC, Meuris S, Puissant F, Hustin J. Morphological aspects of the placentas of HIV pregnancies. Placenta, 1988; 9:633-642.

  4. Chandwani S, Greco MA, Minal K, Antoine C, Krasinski K, Borkowski W. Pathology of human immunodeficiency virus expression in placentas of seropositives women. J Infect Dis, 1991; 163:1134-1138.

  5. Schwartz DA, Sungkarat S, Shaffer N, Laosakkitiboran J, Supapol W, Charoenpanich P et al. Placental abnormalities associated with immunodeficiency virus type 1 infection and perinatal transmission in Bangkok/Thailand. J Infect Dis, 2000; 182:1652-1657.

  6. Bhoopat L, Khunamorpong S, Sirivatanapa P, Rhitaporn T, Lerdsrimongkol P, Thomer PS et al. Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period. Mol Pathol, 2005; 18:1357-136.

  7. Loga FM, Driscoll SG, Munro HN. Comparison of placental from two socioeconomic groups. I. Morphometry. Pediatrics, 1972; 50:24-31.

  8. Bulterys M. HIV During Pregnancy Preventing Vertical HIV Transmission in the Year 2000: Progress and Prospects - A Review. Trophoblast Research, 2001; 15:S5-S12.

  9. Connor E.M, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ et al. Reduction of mateman-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994,331:1173-1180.

  10. Benirschke K, Kaufmann P. Pathology of the Human Placenta 4ta Ed. New York: Springer-Veriag, 2000.

  11. Lewis SH, Perrin E. Pathology of the Placenta. New York: Churchill Livingstone, 1999.

  12. Cytel. Statxact 8. User manual. Cambridge: Cytel software, 2000 pp. 1303.

  13. Majumdar S, Dasgupta H, Bhattacharya K, Bhattacharya A. A study of placenta in normal and hypertensive pregnancies. J Anat Soc India, 2005; 54:1-9.

  14. Anderson VM, Zevallos E, Gu J. The HIV-exposed placenta morphologic observations and interpretation. A review. Trophoblast Research, 1994; 8:47-65.

  15. Austgulen R, Isaksen CV, Chedwick L, Romundstad P, Vatten L, Craven C. Pre-eclampsia: associated with increased syncitial apoptosis when the infant is small for gestational age. J Reprod Immunol, 2004; 61:39-50.

  16. Thiet MP, Suwanvanichkij V, Hasselblatt K, Yeh J. Apoptosis in human term placenta. A morphological and gene expression study. Gynecol Obstet Invest, 2000; 50:88-91.

  17. Collier AC, Helliwell RJ, Keelan JA, Paxton JW, Mitchell MD, Tingle MD. 3'-Azido-3'-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharmacol, 2003; 192:164-173.

  18. Anderson VM. The placental barrier to maternal HIV infection. Obstet Gynecol Clin North Am, 1997; 24:797-820.

  19. Molina VR, Romero AT, Bermúdez I, Flores J, Fuenmayor J, Nunez JR. y cols. Factor de necrosis tumoral-alfa en el suero de embarazadas normales y preeclámpticas. Gac Med Caracas, 2001; 109:526-531.

  20. Mayhew TM, Bowles C, Orme G. A stereological method for testing whether or not there is random deposition of perivillous fibrin-type fibrinoide at the villous surface: description and pilot applications to term placentae. Placenta, 2000; 21:684-692.

  21. Scucces MG, Castejón OC. Lesiones predíctivas de malignidad en la membrana basal de mola hidatidrforme. Rev Obstet Ginecol Venez, 2006;66:151-158.

  22. Horn L, Rose I. Placental and fetal pathology in intrauterine viral infections. Intervirology, 1998;41:219-225.

  23. Wang X, Atthayde N, Trudinger B. A proinflamatory cytokine response is present in the fetal placental vasculature in placental insufficiency. Am J Obstet Ginecol, 2003; 189:1445-1451.

  24. Pornprasert S, Faye A, Mary JY, Dolcini G, Leechanachai P, Chaouat G, Ngo N, Barré-Sinoussi F, Menu E. Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta, 2006; 27:989-995.

  25. Nesmann C, Laroche JC. Atlante di patología placentare. Roma: Edizioni Internazionali, 2001.

  26. Bailáo LA, Osborne NG, Rizzi MC, Bonilla-Musoles F, Duarte G, Bailáo TC. Ultrasound markers of fetal infection part 1: viral infections. Ultrasound Q, 2005; 21:295-308

  27. Villegas H, Carrillo J, Paredes Y, Barron A, Karchmer S. Estudio ultraestructural de placentas en mujeres seropositivas para el VIH-1. Ginecol Obstet Méx, 1994; 62:136-152.

  28. Poqqui SH, Bostrom Kl, Demer LL, Skinner HC, Koos BJ. Placental calcification: a metastatic process? Placenta, 2001; 22:591-596.

  29. Agababov RM, Abashina TN, Suzina NE, Vainshtein MB, Schwartsburd PM. Link between the early calcium deposition in placenta and nanobacterial - like infection. J Biosci, 2007; 32:1163-1168.

  30. Castejón OC, Molinaro VMP. Cambios degenerativos coríónicos y su relación con desórdenes hipertensivos en casos de desprendimiento prematuro grave de placenta normoinserta. Gac Méd Caracas, 2003; 111:117-122.

  31. Backé E, Jimenez E, Unger M, Scháfer A, Vocks-Hauck M, Grosch-Wórner I, Vogel M. Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors. Am J Perinatal, 1994; 11:326-330.

  32. Tscherning-Casper C, Papadogiannakis N, Anvret M, Stolpe L, Lindgren S, Bohlin AB, Albert J, Fenyó EM. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol, 1999; 73:9673-9678.

  33. Pollioti BM, Gnall-Sazenski S, Langhlin TS, Miller RK. Inhibitory effects of human chorionic gonadotropin (hcG) preparations on HIV infection of human placenta in vitro. Placenta, 2002; 23:102-110.

  34. Castejón SOC, López GAJ, Pérez Y LM, Castejón MOC. Alteraciones morfológicas en el espacio intervelloso y en los vasos de vellosidades troncales de embarazadas infectadas con vih-1 tratadas con zidovudina. Rev Electr Portales Medicos.com 2009; 4:19;442.

  35. Castejón S OC, López GAJ; Castejón MOC. Aspectos Ultraestructurales de la vellosidad placentaria infectada por vih y tratada con zidovudina. Ginecol Obstet Mex 2010; 78:335-344.

  36. Villegas CH, Carrillo FJ, Paredes V Y, Flores RE, Arredondo GJL, Gorbea RM. Estudio comparativo de la placenta de madres seropositivas a vih. Análisis Ultraestructural. Ginecol Obstet Mex 1996; 64:167-176.

  37. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol, 2009; 8:110-124.

  38. Vidricaire G, Tremblay MJ. For a better understanding of the mechanisms involved in vertical transmisión of HIV. Med Sci (Paris), 2004; 20:784-787.

  39. Al-Husaini AM. Role of placenta in the vertical transmission of human immunodeficiency virus. J Perinatal, 2009; 29:331-336.




2020     |     www.medigraphic.com